From billionaire-backed biotech to promising animal studies, this early trial will test whether partial reprogramming can ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

Scientists at Life Biosciences are preparing to begin testing partial reprogramming in people. It will mark the first time ...

India, April 13 -- Life Biosciences, a clinical-stage biotechnology company focused on reversing diseases of aging, has ...

Dr. Lun Yu explains how advanced molecular design can enable peptides to target the biological roots of skin ageing, turning longevity science into actionable innovation ...

The capacity of an organism to regenerate depends on cell dedifferentiation followed by proliferation. Mammals, in general, have limited regenerative capacity. Now, a team of researchers at the Salk ...